Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Meta-Analysis
. 2021 Jun;52(2):499-507.
doi: 10.1007/s12029-021-00643-9. Epub 2021 May 5.

Depression and Anxiety Among Patients with Cancer During COVID-19 Pandemic: A Systematic Review and Meta-analysis

Erfan Ayubi  1   2   3 , Saeid Bashirian  4 , Salman Khazaei  5   6   7
Affiliations
Meta-Analysis

Depression and Anxiety Among Patients with Cancer During COVID-19 Pandemic: A Systematic Review and Meta-analysis

Erfan Ayubi et al. J Gastrointest Cancer. 2021 Jun.

Abstract

Background: Investigations about the impact and consequences of the COVID-19 infection on the mental health of patients with chronic diseases and those with immunosuppressive conditions are growing. The current study aimed to systematically review and meta-analysis of studies that evaluated the level of depression and anxiety in cancer patients during the COVID-19 pandemic.

Methods: The PubMed, Scopus and Web of Sciences databases were searched to retrieve potential studies from January 2020 to 3 January 2021. Summary data on frequency and mean of depression and anxiety were extracted. Random-effect meta-analysis was conducted to estimate overall prevalence, mean and standardized mean difference.

Results: Thirty-four studies were included in the systematic review, of them 21 studies included in meta-analysis. Overall depression and anxiety were 0.37 (0.27, 0.47); I2 = 99.05%, P value < 0.001 and 0.38 (0.31, 0.46); I2 = 99.08%, P value < 0.001, respectively. Compared to controls, cancer patients had higher anxiety level [standard mean difference (SMD 0.25 (95% CI 0.08, 0.42)].

Conclusion: Overall, the findings of this study suggest that the prevalence of depression and anxiety among patients with cancer during the COVID-19 pandemic can reach considerable levels, although observed substantial heterogeneity should be considered when interpreting the results.

Keywords: Anxiety; COVID-19; Cancer patients; Coronavirus; Depression; Systematic review and meta-analysis.

PubMed Disclaimer

Figures

Fig. 1
Fig. 1
PRISMA flow diagram of the systematic review and meta-analyses selection process
Fig. 2
Fig. 2
Forest plot of random meta-analysis for prevalence of depression among patients with cancer
Fig. 3
Fig. 3
Forest plot of random meta-analysis for prevalence of anxiety among patients with cancer
Fig. 4
Fig. 4
Forest plot of random meta-analysis for mean difference of anxiety among patients with cancer; GAD-7; Generalized Anxiety Disorder Questionnaire, HADS-A; Hospital Anxiety and Depression Scale-depression, SAS; Self-Rating Anxiety Scale; SDM; standardized mean difference
See this image and copyright information in PMC

References

    1. Worldometer. COVID-19 Coronavirus Pandemic 2020 [updated January 19, 2021. Available from: https://www.worldometers.info/coronavirus/.
    1. Deng G, Yin M, Chen X, Zeng F. Clinical determinants for fatality of 44,672 patients with COVID-19. Critical care (London, England) 2020;24(1):179. doi: 10.1186/s13054-020-02902-w. - DOI - PMC - PubMed
    1. Wang Q, Berger NA, Xu R. Analyses of risk, racial disparity, and outcomes among US patients with cancer and COVID-19 infection. JAMA oncology. 2020. - PMC - PubMed
    1. Williamson EJ, Walker AJ, Bhaskaran K, Bacon S, Bates C, Morton CE, et al. Factors associated with COVID-19-related death using OpenSAFELY. Nature. 2020;584(7821):430–436. doi: 10.1038/s41586-020-2521-4. - DOI - PMC - PubMed
    1. Burki TK. Cancer guidelines during the COVID-19 pandemic. Lancet Oncol. 2020;21(5):629–630. doi: 10.1016/S1470-2045(20)30217-5. - DOI - PMC - PubMed